Consistent increment in the number of patients suffering from sleep disorders, respiratory diseases, and obesity are major factors for the growth of continuous positive airway pressure (CPAP) devices market. As per WHO, in 2016, over 1.9 billion adults were overweight, and more than 650 million were obese.
It is estimated that more, than 350 million people are suffering from sleep disorders, as per the Centre for Disease Control and Prevention. Advancements in technology such as improved oral appliance and improved mask designs are likely to propel the market over the forecast period.
The market is expected to witness significant growth, owing to the launch of technology-advanced CPAP devices, increasing market consolidation activities, and infrastructure improvements in the medical field of CPAP devices.
Find Out More about the Report Coverage
- Medtronic Plc.
- Smiths Group plc.
- Koninklijke Philips N.V.
- Draegerwerk AG & Co. KGaA
- Fisher & Paykel Healthcare
- Hamilton Medical AG
- ResMed Inc.
- DeVilbiss Healthcare LLC
- 3B Medical, Inc.
- BMC Medical Co. Ltd
Rising Prevalence of Sleep Disorders & Chronic Respiratory Diseases Aiding CPAP Devices Market Growth
As per the WHO, sleep disorders therapeutic and breathing issues is the most common condition affecting 1 to 6% adults. Sleep apnea is more common in adults and older individuals. As per a report of The Global Impact of Respiratory Disease, 24% men aged 30–60 years had obstructive sleep apnea.
Paediatric sleep disorders are increasingly recognised as the causes of morbidity and mortality. Sleep disorders are associated with many other illnesses such as stroke, cardiovascular diseases, and metabolic disorders.
According to the WHO, around 65 Mn people have moderate to severe COPD. Prevalence is also on the rise for people suffering from COPD, with three million deaths in 2015, which corresponds to 5% of all global deaths in 2015. This, in turn, is expected to increase the growth of the continuous positive airway pressure devices market over the coming years.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
COVID-19 Impact Propelling Demand for CPAP Devices
With the increasing cases of COVID-19 worldwide, there is need for effective management of the infection using CPAP therapy. A shortage of ventilators during this pandemic has compelled healthcare professionals to opt for alternative methods to deliver respiratory support to patients affected with COVID 19.
Necessary modifications required to convert CPAP devices to treat respiratory insufficiency have been designed to minimize aerosolization. These factors are playing an important role in driving the growth of the continuous positive airway pressure devices market.
For instance, ResMed’s focus is to maximize the availability of respiratory support devices to treat the respiratory complications of COVID-19.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Continuous Technological Advancements in CPAP Devices
The continuous positive airway pressure devices market has been witnessing significant growth, owing to consistent introduction of new capabilities that are designed to meet the needs of individual patients. Auto-adjusting devices (autotitrating) monitor the breathing patterns of the user, and outputs the right amount of pressure at the right time to prevent apnea, with maximum comfort.
This results in regularly and effectively treating dangerous sleep disorders of patients, which makes therapy more comfortable. CPAP devices come with data storage capabilities, which helps healthcare professionals produce better clinical outcomes with greater accuracy.
Technological advancements in CPAP technology are aimed at improving the therapy experience for patients with sleep apnea, and this is likely to drive the demand for continuous positive airway pressure devices.
Explore Persistence Market Research’s expertise in promulgation of the business !
Regional Analysis of Continuous Positive Airway Pressure Devices Market
North America remains the most lucrative region with a significant market share of close to 37% in the global CPAP devices market. Increased demand for continuous positive airway pressure machines and rising prevalence of sleep disorders are factors contributing to the dominance of North America in the global continuous positive airway pressure devices market.
Well-defined regulatory guidelines and increasing investments in research & development for new devices are key factors responsible for the growth of the Europe continuous positive airway pressure devices market.
High prevalence of chronic sleep disorders coupled with increasing awareness among patients is anticipated to boost the demand for CPAP devices in Asia Pacific, in turn, driving the growth of the regional market.
Continuous Positive Airway Pressure Devices - Competitive Landscape
The continuous positive airway pressure devices market is mostly dominated by key players, while the remaining market is characterized as a fragmented market. Prime players across the globe are Medtronic Plc, Smiths Group plc, Koninklijke Philips N.V, ResMed Inc., Draegerwerk AG & Co. KGaA, etc. Manufacturers are actively involved in collaborations for product development and geographic expansion to gain a larger market share in the continuous positive airway pressure devices market.
Increasing prevalence of sleep apnea owing to rise in cardiovascular diseases, diabetes, and other diseases, globally, is a factor offering strong impetus to the growth of the continuous positive airway pressure devices market. The launch of advanced technological devices prominently accounts for the growing popularity of sleep apnea diagnostic systems across developing regional markets.
Consistent rise in the number of manufacturers and distributors is likely to contribute to the growth of the CPAP devices market in the near future.
Key Segments of Continuous Positive Airway Pressure Devices Market
Key Questions Answered in Report
- How much is the Continuous Positive Airway Pressure (CPAP) devices market worth?
The global Continuous Positive Airway Pressure (CPAP) devices market is expected to be worth US$ 6 Bn by the year 2031.
- What will be the demand outlook?
The global Continuous Positive Airway Pressure (CPAP) devices market is expected to witness a CAGR of 6.8% between 2021 and 2031.
- What was the last 5 year market CAGR?
The global Continuous Positive Airway Pressure (CPAP) devices market witnessed a CAGR of 5.7% between 2015 and 2020.
- What are the key trends of Continuous Positive Airway Pressure (CPAP) devices market?
The latest trend pertains to technological advancements in Continuous Positive Airway Pressure (CPAP) devices.
- What is driving the demand for Continuous Positive Airway Pressure (CPAP) devices?
Increasing incidences of cardiac disorders are driving the demand for Continuous Positive Airway Pressure (CPAP) devices.
- What is the market share of top 5 players?
The top 5 players such as Medtronic Plc, Smiths Group plc, Draegerwerk AG & Co. KGaA, Hamilton Medical AG, and Fisher & Paykel Healthcare hold more than 30% of the market share.
- What are the top 5 countries driving demand?
The top 5 countries driving demand include the US, The Netherlands, UK, Germany, and Russia.
- What is North America’s market Outlook?
North America holds more than 30% of the market share due to the US holding the baton.
- At what percentage Continuous Positive Airway Pressure (CPAP) devices market is going to register growth in Europe?
Europe is expected to register growth at the rate of 4% in the Continuous Positive Airway Pressure (CPAP) devices market between 2021 and 2031.
- Which are the key exporters of Continuous Positive Airway Pressure (CPAP) devices?
The key exporters of Continuous Positive Airway Pressure (CPAP) devices are the US, Germany, and The Netherlands.